Correlation Between Nuvectis Pharma and Viridian Therapeutics
Can any of the company-specific risk be diversified away by investing in both Nuvectis Pharma and Viridian Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nuvectis Pharma and Viridian Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nuvectis Pharma and Viridian Therapeutics, you can compare the effects of market volatilities on Nuvectis Pharma and Viridian Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nuvectis Pharma with a short position of Viridian Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nuvectis Pharma and Viridian Therapeutics.
Diversification Opportunities for Nuvectis Pharma and Viridian Therapeutics
0.69 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Nuvectis and Viridian is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding Nuvectis Pharma and Viridian Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Viridian Therapeutics and Nuvectis Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nuvectis Pharma are associated (or correlated) with Viridian Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Viridian Therapeutics has no effect on the direction of Nuvectis Pharma i.e., Nuvectis Pharma and Viridian Therapeutics go up and down completely randomly.
Pair Corralation between Nuvectis Pharma and Viridian Therapeutics
Given the investment horizon of 90 days Nuvectis Pharma is expected to generate 1.46 times less return on investment than Viridian Therapeutics. In addition to that, Nuvectis Pharma is 1.42 times more volatile than Viridian Therapeutics. It trades about 0.04 of its total potential returns per unit of risk. Viridian Therapeutics is currently generating about 0.09 per unit of volatility. If you would invest 1,447 in Viridian Therapeutics on November 2, 2024 and sell it today you would earn a total of 561.00 from holding Viridian Therapeutics or generate 38.77% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Nuvectis Pharma vs. Viridian Therapeutics
Performance |
| Timeline |
| Nuvectis Pharma |
| Viridian Therapeutics |
Nuvectis Pharma and Viridian Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Nuvectis Pharma and Viridian Therapeutics
The main advantage of trading using opposite Nuvectis Pharma and Viridian Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nuvectis Pharma position performs unexpectedly, Viridian Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Viridian Therapeutics will offset losses from the drop in Viridian Therapeutics' long position.| Nuvectis Pharma vs. Replimune Group | Nuvectis Pharma vs. Lyra Therapeutics | Nuvectis Pharma vs. Kronos Bio | Nuvectis Pharma vs. Gossamer Bio |
| Viridian Therapeutics vs. Nuvalent | Viridian Therapeutics vs. Arcellx | Viridian Therapeutics vs. Vaxcyte | Viridian Therapeutics vs. Crinetics Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |